2015
Enteric‐coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal‐transplant recipients compared with mycophenolate mofetil
Feng J, Zhang L, Zhao P, Bow L, Tian J. Enteric‐coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal‐transplant recipients compared with mycophenolate mofetil. International Journal Of Clinical Practice Supplement 2015, 69: 1-7. PMID: 26176848, DOI: 10.1111/ijcp.12660.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAdultChinaDose-Response Relationship, DrugEnzyme InhibitorsFemaleFollow-Up StudiesGraft RejectionHumansImmunosuppressive AgentsIncidenceKidney TransplantationMaleMiddle AgedMycophenolic AcidProspective StudiesSurgical Wound InfectionTablets, Enteric-CoatedTacrolimusTransplant RecipientsConceptsAsian renal transplant recipientsRenal transplant recipientsEnteric-coated mycophenolate sodiumEC-MPSMycophenolate sodiumMMF groupIncidence of infectionMycophenolate mofetilSerious infectionsAdverse eventsLower incidenceTherapeutic effectLive donor kidney transplant recipientsInfection rateGastro-intestinal adverse eventsClinical trial registration numberIncidence of biopsyPosttransplant infection ratesTimes of diarrheaKidney transplant recipientsSerum creatinine levelsTRIAL REGISTRATION NUMBEREnteric-coated formulationAcute rejectionRenal transplantation
2001
Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization
Benedetto B, Lipkowitz G, Madden R, Kurbanov A, Hull D, Miller M, Bow L. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. Journal Of Vascular Surgery 2001, 34: 139-142. PMID: 11436087, DOI: 10.1067/mva.2001.114206.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedArteriovenous Shunt, SurgicalCadaverCryopreservationDimethyl SulfoxideFemaleHumansKidney TransplantationMaleMiddle AgedTransplantation, HomologousConceptsVein allograftsHemodialysis accessPRA valuesControl cohortPRA assaysWaiting listKidney transplantation waiting listPanel-reactive antibodies valuesPotential kidney transplant recipientsUniversity-affiliated medical centerMajor histocompatibility complex IKidney transplant recipientsHistory of transfusionTransplant waiting listTransplantation waiting listMean PRANonimmunosuppressed individualsHemodialysis populationKidney transplantationPrior transplantationTransplant recipientsConsecutive patientsProsthetic graftsAntibody valuesKidney failure
2000
Response to “A Novel United Network for Organ Sharing Region Kidney Allocation Plan Improves Transplant Access for Minority Candidates”
Hull D, Bow L, Mather J. Response to “A Novel United Network for Organ Sharing Region Kidney Allocation Plan Improves Transplant Access for Minority Candidates”. Transplantation 2000, 70: 1113. PMID: 11045655, DOI: 10.1097/00007890-200010150-00024.Peer-Reviewed Original Research
1999
A new allocation plan for renal transplantation
Delmonico F, Harmon W, Lorber M, Goguen J, Mah H, Himmelfarb J, Lipkowitz G, Valliere S, Bow L, Milford E, Rohrer R. A new allocation plan for renal transplantation. Transplantation Proceedings 1999, 31: 358-359. PMID: 10083141, DOI: 10.1016/s0041-1345(98)01660-1.Peer-Reviewed Original ResearchA NEW ALLOCATION PLAN FOR RENAL TRANSPLANTATION1
Delmonico F, Harmon W, Lorber M, Goguen J, Mah H, Himmelfarb J, Lipkowitz G, Valliere S, Bow L, Milford E, Rohrer R. A NEW ALLOCATION PLAN FOR RENAL TRANSPLANTATION1. Transplantation 1999, 67: 303-309. PMID: 10075599, DOI: 10.1097/00007890-199901270-00021.Peer-Reviewed Original ResearchConceptsDR mismatchesTransplant centersDonor availabilityPanel reactive antibodyPercentage of patientsMultiple transplant centersNumber of patientsAllograft allocationRENAL TRANSPLANTATION1Renal transplantationNegative patientsPediatric patientsHLA matchingUnited NetworkCadaver donorsDonor hospitalPatientsInterval changesKidneyTotal numberHLA pointsTime waitingTRANSPLANTATION1TransplantationHLA
1996
Organ transplantation at the Hartford Transplant Center.
Schweizer R, Bartus S, Hull D, Perdrizet G, Swanson M, Low H, Gallagher R, Dougherty J, Rosson R, Hyams J, D'Avella J, Rasoulpour M, Sullivan P, Bow L. Organ transplantation at the Hartford Transplant Center. Connecticut Medicine 1996, 60: 387-93. PMID: 8758656.Peer-Reviewed Original ResearchConceptsTransplant centersActuarial graft survivalRecipients of kidneysMost transplant centersTwo-year survivalHealth care communityTriple immunosuppressionGraft survivalKidney transplantationLiver transplantRelated donorsCadaveric kidneysHigh success rateDonor organsOrgan transplantationOrgan transplantsPancreas patientsKidneySuccess rateSurvivalTransplantationTransplantNational averageHeartImmunosuppression
1993
Causes of late graft failure in cadaveric renal transplantation.
Bergmann L, Roper L, Bow L, Hull D, Bartus S, Schweizer R. Causes of late graft failure in cadaveric renal transplantation. Transplantation Proceedings 1993, 25: 1340-1. PMID: 8442136.Peer-Reviewed Original Research
1992
Late graft loss in cadaveric renal transplantation.
Bergmann L, Roper L, Bow L, Hull D, Bartus S, Schweizer R. Late graft loss in cadaveric renal transplantation. Transplantation Proceedings 1992, 24: 2718-9. PMID: 1465913.Peer-Reviewed Original Research
1989
Transplantation of cadaver kidneys from pediatric and older donors.
Bow L, Roper L, Bartus S, Hull D, Schweizer R. Transplantation of cadaver kidneys from pediatric and older donors. Transplantation Proceedings 1989, 21: 1938-9. PMID: 2652632.Peer-Reviewed Original Research
1988
Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
Schweizer R, Bow L, Roper L, Hull D, Bartus S. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression. Clinical Transplants 1988, 147-58. PMID: 3154467.Peer-Reviewed Original ResearchConceptsLiving-related donor kidney transplantsDonor kidney transplantsCadaver kidney transplant recipientsKidney transplant recipientsGraft survivalKidney transplantOKT3 therapyTriple immunosuppressionTransplant recipientsHartford HospitalControl groupPretransplant blood transfusionsPrevious control groupSteroid-resistant rejectionUse of OKT3Year graft survivalMean serum creatinineEuro-Collins solutionAddition of CsAKidney transplantationRenal transplantationCMV infectionSerum creatinineBlood transfusionDR matching
1986
USE OF TWO DONOR-SPECIFIC TRANSFUSIONS FOR LIVING -RELATED DONOR KIDNEY TRANSPLANTATION
Schweizer R, Bartus S, Rovelli M, Bow L. USE OF TWO DONOR-SPECIFIC TRANSFUSIONS FOR LIVING -RELATED DONOR KIDNEY TRANSPLANTATION. Transplantation 1986, 42: 564-567. PMID: 3538543, DOI: 10.1097/00007890-198611000-00026.Peer-Reviewed Original Research
1982
Serologic considerations in donor-specific transfusion therapy for kidney transplantation.
Schweizer R, Bow L, Generas D, Bartus S. Serologic considerations in donor-specific transfusion therapy for kidney transplantation. Transplantation Proceedings 1982, 14: 374-7. PMID: 6810522.Peer-Reviewed Original Research
1981
Beta 2-microglobulin monitoring after renal transplantation.
Schweizer R, Moore R, Bartus S, Bow L, Hayden J. Beta 2-microglobulin monitoring after renal transplantation. Transplantation Proceedings 1981, 13: 1620-3. PMID: 6171078.Peer-Reviewed Original Research